🎥 Dr. Gengqing Song speaks with Dr. Yessica Pontet about a predictive model for duodenal atrophy in adult celiac disease—and whether diagnostic endoscopy may be avoided in selected patients.
Key findings, limitations & clinical implications.
▶️ https://t.co/GvndghvtUR
🧩 New in JCG: In longstanding UC, patient-reported symptoms were largely independent of disease extent.
Across Montreal phenotypes, symptom burden was similar—highlighting the need to look beyond anatomic extent when assessing UC experience.
https://t.co/snPBm64s3V
🚗 New in JCG: Can healthy patients drive after colonoscopy with >200 mg propofol?
In this prospective study, no accidents occurred within 24 hrs, and 99% would repeat the same approach.
Important—but practice should still follow local sedation policies.
https://t.co/jSbSBJH3yP
🩸 New in JCG (May/June 2026)
In a national inpatient analysis, HIV-positive patients with variceal upper GI bleeding had higher mortality, ICU use, and hospital costs than matched non-HIV patients.
Important data for risk-aware inpatient care.
https://t.co/43NzSpvmHO
🧫 New in JCG (May/June 2026)
Should all patients with biliary obstruction receive antibiotics before ERCP?
This meta-analysis of 11 RCTs found prophylaxis reduced infectious complications and bacteremia after ERCP.
📖 https://t.co/ar85jgQcH2
#ERCP#Endoscopy#Biliary#JCG
👉🏼 Our study at @JCGjournal
demonstrates higher effectiveness of upadacitinib compared with ustekinumab in UC patients with prior anti-TNF exposure 📊, with lower 1-year corticosteroid use observed in the upadacitinib group (40.1% vs 48.5%) 💊
📚 https://t.co/zZn7L4gbJY
@TandonKp@ElfertKhaled@MouhandMD@alkasabrah
🌍 New in JCG (May/June 2026)
Patients whose primary language is not English had higher odds of early repeat screening colonoscopy (≤1 yr) and CRC detection.
Language-tailored prep may reduce repeat procedures and improve equity.
https://t.co/yHUsWigbpJ
WGO News: Celebrate World Digestive Health Day 2026 on May 29:“Chronic Diarrhea: Don’t Flush the Signs Away”
Also, register for WCOG 2026 in New Delhi, Sept 30-Oct 3.
🔗 https://t.co/NRt63GTbJF
New in JCG (May/June 2026): Nitazoxanide-based triple therapy shows higher H. pylori eradication rates than standard triple therapy in an updated RCT meta-analysis. Promising option amid rising antibiotic resistance.
https://t.co/CeYiSgIEAO
🎥 New in JCG (Apr 2026): A design-thinking approach created educational videos + website for Crohn’s perianal fistula, significantly improving patient activation (PAM).
A promising model for patient-centered digital education.
https://t.co/OtwFFTsY7U
📰 New in JCG (Apr 2026): Did media coverage of the NordICC trial change public views on colonoscopy? In a US national sample, a lower-quality vs higher-quality news article did not significantly alter screening intent.
https://t.co/6v42UX3fMv
🤖 New in JCG (Apr 2026): Machine learning shows strong performance in predicting mortality in acute pancreatitis
📊 C-index ~0.84 (vs ~0.75 for traditional scores)
Potential to improve early risk stratification & clinical decision-making
https://t.co/M8cJFqjVsG
🧪 New in JCG (Apr 2026)
A predictive model suggests tTG >5.5× ULN achieves 100% specificity for duodenal atrophy in adult celiac disease, potentially avoiding diagnostic endoscopy in select patients.
https://t.co/FiCXHll8ix
🎥 JCG Spotlight
Dr. Gengqing Song speaks with Dr. Rakahn Haddadin on global safety outcomes of gastrostomy, comparing endoscopic, radiologic, and surgical approaches.
Key findings, risks & clinical implications.
https://t.co/ENu26peHkg
🧪 New in JCG (Apr 2026)
Can biopsy be avoided in adult celiac disease?
tTG >5.5× ULN showed 100% specificity for villous atrophy, supporting a potential non-biopsy diagnostic approach in selected patients.
https://t.co/FiCXHll8ix
🌏 WGO News- JCG (Apr 2026)
Join #WCOG2026 in New Delhi (Sept 30-Oct 3), a global forum advancing GI science & collaboration.
WGO also welcomes its new Governing Council led by Prof. Carolina Olano.
https://t.co/6cPjxZjfYM
🦠 New in JCG (Apr 2026): Analysis of 130M+ patients (TriNetX) shows GERD and related conditions are linked to higher risk of nontuberculous mycobacterial (NTM) infection. Risk increased across GERD phenotypes and complications.
https://t.co/lBrv8ce9sj
🔬 New in JCG (Apr 2026): The TSP-9 tissue systems pathology test helps stratify risk in Barrett’s esophagus.
Meta-analysis (n=699) shows strong prediction of progression to HGD/EAC (HR ~6.7) with 97% NPV, aiding surveillance and escalation decisions.
https://t.co/oVnr2OMfyu